Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target, REalloys to Appoint Bob Foresman to its Board of Directors

Stock Information for Sonnet BioTherapeutics Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sonnet BioTherapeutics Holdings Inc.

Blackboxstocks and REalloys Announce Closing of Merger; REalloys to Begin Trading on Nasdaq Under Ticker "ALOY"
Blackboxstocks Announces that NASDAQ Approves Listing of REalloys; Merger Expected to Close Today after Close of the Market
Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors
Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys Inc. and AltynGroup Kazakhstan Sign Series of Agreements to Secure Kazakhstan Rare Earth Feedstock for U.S. Government Defense Stockpiles
Blackboxstocks (NASDAQ: BLBX) Merger Target, REalloys and Mission Critical Materials Form Strategic Partnership to Build First U.S. Mine-Waste-to-Magnet Supply Chain
Blackboxstocks Inc. Merger Target REalloys Enters into Historic Partnership with the SRC to Establish North America's First Commercial-Scale Heavy Rare Earth Production
Blackboxstocks, Inc (NASDAQ: BLBX) Merger Target, REalloys Secures $200 Million Letter of Interest from U.S. EXIM Bank to Advance North America's First Fully Integrated Mine-to-Magnet Supply Chain
Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REAlloys Inc. and Japanese Government's 'JOGMEC' Sign Strategic MOU to Strengthen U.S., Japan Rare Earth Supply Chain

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.